These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3302206)

  • 1. Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei.
    Narumiya S; Ohno K; Fukushima M; Fujiwara M
    J Pharmacol Exp Ther; 1987 Jul; 242(1):306-11. PubMed ID: 3302206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.
    Narumiya S; Ohno K; Fujiwara M; Fukushima M
    J Pharmacol Exp Ther; 1986 Nov; 239(2):506-11. PubMed ID: 3772805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.
    Narumiya S; Fukushima M
    J Pharmacol Exp Ther; 1986 Nov; 239(2):500-5. PubMed ID: 3772804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the transport system of prostaglandin A2 in L-1210 murine leukemia cells.
    Ohno K; Hirata M
    Biochem Pharmacol; 1993 Aug; 46(4):661-70. PubMed ID: 8363639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of cell cycle by metabolites of prostaglandin D2 through a non-cAMP mediated mechanism.
    Hughes-Fulford M; Fukushima M
    Life Sci Adv Exp Clin Endocrinol; 1993; 12():57-64. PubMed ID: 11539936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active transport and cellular accumulation of cyclopentenone prostaglandins: a mechanism of prostaglandin-induced growth inhibition.
    Narumiya S; Fukushima M
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():972-5. PubMed ID: 2960214
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1.
    Bogaards JJ; Venekamp JC; van Bladeren PJ
    Chem Res Toxicol; 1997 Mar; 10(3):310-7. PubMed ID: 9084911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.
    Ohno K; Sakai T; Fukushima M; Narumiya S; Fujiwara M
    J Pharmacol Exp Ther; 1988 Apr; 245(1):294-8. PubMed ID: 3361448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells.
    Kim IK; Lee JH; Sohn HW; Kim HS; Kim SH
    FEBS Lett; 1993 Apr; 321(2-3):209-14. PubMed ID: 8477853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition.
    Narumiya S; Fukushima M
    Biochem Biophys Res Commun; 1985 Mar; 127(3):739-45. PubMed ID: 3857041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antineoplastic prostaglandins].
    Fukushima M
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1930-5. PubMed ID: 6577812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues.
    Bregman MD; Funk C; Fukushima M
    Cancer Res; 1986 Jun; 46(6):2740-4. PubMed ID: 3698005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
    Kato T; Fukushima M; Kurozumi S; Noyori R
    Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture.
    Bhuyan BK; Adams EG; Badiner GJ; Li LH; Barden K
    Cancer Res; 1986 Apr; 46(4 Pt 1):1688-93. PubMed ID: 3456266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glutathione content on cellular uptake and growth inhibitory activity of prostaglandin A2 in L-1210 cells.
    Ohno K; Hirata M; Narumiya S; Fukushima M
    Eicosanoids; 1992; 5(2):81-5. PubMed ID: 1449820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic dehydration of prostaglandin E2 and cellular uptake of the dehydration product: correlation with prostaglandin E2-induced growth inhibition.
    Ohno K; Fujiwara M; Fukushima M; Narumiya S
    Biochem Biophys Res Commun; 1986 Sep; 139(2):808-15. PubMed ID: 3464277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen.
    Khan SH; Sorof S
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9401-5. PubMed ID: 2251282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of c-Myc and heat shock protein 70 in human hepatocarcinoma Hep3B cells during apoptosis induced by prostaglandin A2/Delta12-prostaglandin J2.
    Ahn SG; Jeong SY; Rhim H; Kim IK
    Biochim Biophys Acta; 1998 Nov; 1448(1):115-25. PubMed ID: 9824682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc suppression and cell cycle arrest at G1 phase by prostaglandins.
    Marui N; Sakai T; Hosokawa N; Yoshida M; Aoike A; Kawai K; Nishino H; Fukushima M
    FEBS Lett; 1990 Sep; 270(1-2):15-8. PubMed ID: 2226777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60.
    Ishioka C; Kanamaru R; Sato T; Dei T; Konishi Y; Asamura M; Wakui A
    Cancer Res; 1988 May; 48(10):2813-8. PubMed ID: 3162825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.